Transmission electron micrograph of SARS-CoV-2 virus particles captured by NIAID
The AI model uses data from the COVID Symptom Study app to predict COVID-19 infection.
Researchers at King’s College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based on their symptoms. Their findings are published today in Nature Medicine.
The AI model uses data from the COVID Symptom Study app to predict COVID-19 infection, by comparing people’s symptoms and the results of traditional COVID tests. Researchers say this may provide help for populations where access to testing is limited. Two clinical trials in the UK and the US are due to start shortly.
More than 3.3 million people globally have downloaded the app and are using it to report daily on their health status, whether they feel well or have any new symptoms such as persistent cough, fever, fatigue and loss of taste or smell (anosmia).
In this study, the researchers analysed data gathered from just under 2.5 million people in the UK and US who had been regularly logging their health status in the app, around a third of whom had logged symptoms associated with COVID-19. Of these, 18,374 reported having had a test for coronavirus, with 7,178 people testing positive.
The research team investigated which symptoms known to be associated with COVID-19 were most likely to be associated with a positive test. They found a wide range of symptoms compared to cold and flu, and warn against focusing only on fever and cough. Indeed, they found loss of taste and smell (anosmia) was particularly striking, with two thirds of users testing positive for coronavirus infection reporting this symptom compared with just over a fifth of the participants who tested negative. The findings suggest that anosmia is a stronger predictor of COVID-19 than fever, supporting anecdotal reports of loss of smell and taste as a common symptom of the disease.
The researchers then created a mathematical model that predicted with nearly 80% accuracy whether an individual is likely to have COVID-19 based on their age, sex and a combination of four key symptoms: loss of smell or taste, severe or persistent cough, fatigue and skipping meals. Applying this model to the entire group of over 800,000 app users experiencing symptoms predicted that just under a fifth of those who were unwell (17.42%) were likely to have COVID-19 at that time.
Researchers suggest that combining this AI prediction with widespread adoption of the app could help to identify those who are likely to be infectious as soon as the earliest symptoms start to appear, focusing tracking and testing efforts where they are most needed.
Our results suggest that loss of taste or smell is a key early warning sign of COVID-19 infection and should be included in routine screening for the disease. We strongly urge governments and health authorities everywhere to make this information more widely known, and advise anyone experiencing sudden loss of smell or taste to assume that they are infected and follow local self-isolation guidelines.– Professor Tim Spector, King’s College London
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Artificial Intelligence Market Overview By Share, Size, Industry Players, Revenue And Product Demand Forecast Till 2025on June 23, 2020 at 8:36 am
In this report, the Global Artificial Intelligence (AI) market was valued at USD 11.71 Billion in 2016, and is projected ...
- AI-Enhanced Predictive Models to Combat the Next COVID Waveon June 23, 2020 at 7:57 am
All the most promising new models that provide COVID-19 predictions are under considerable scrutiny within the scientific community. How can we do this better? Why not adopt a cutting-edge artificial ...
- Artificial Intelligence (AI) Market Trends, Size, Shares, Overview and Forecast by 2020-2027on June 23, 2020 at 5:22 am
As per the research held by Acumen Research and Consulting, "the global Artificial Intelligence (AI) market anticipated to exceed US$ 160 Bn by 2027, along with the projected CAGR of 49% from 2020 to ...
- AI researchers say scientific publishers help perpetuate racist algorithmson June 23, 2020 at 3:56 am
An open letter from a growing coalition of AI researchers is calling out scientific publisher Springer Nature for a conference paper it originally planned to include in its forthcoming book ...
- Growth Opportunities in the Global Mobile Handset Market to 2024 - Handsets as AI Assistantson June 23, 2020 at 1:07 am
The "Global Mobile Handset Market, Forecast to 2024" report has been added to ResearchAndMarkets.com's offering. In 2019,.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
AI predicting COVID-19 infection
- Repurpose.AI and Scripps Research Announce a Collaboration to Discover COVID-19 Therapeuticson June 23, 2020 at 10:10 am
Repurpose.AI, an AI drug discovery company, today announced a collaboration with Scripps Research to develop COVID-19 therapeutics.
- Epidemiological models predicting Covid-19 infections in SA not an exact scienceon June 23, 2020 at 2:25 am
A new epidemiological model has put at 570 000 the number of people who could eventually be infected with Covid-19 in South Africa.
- C3.ai's Digital Transformation Institute issues awards for data-driven COVID-19 researchon June 22, 2020 at 9:01 pm
The research projects looked at COVID-19 as well as its impact on housing precarity, eviction and inequality as well as the role of social determinants on health and using data science to detect and ...
- Use AI responsibly to uplift historically disenfranchised people during COVID-19on June 22, 2020 at 7:26 am
In the rush to “help now,” we cannot throw responsible AI out the window. In fact, in the age of COVID-19 is more important than ever before to understand the unintended consequences and long term ...
- Nanosponges Soak Up Virus, AI Tracks Mutations: The Week’s COVID-19 Updateson June 19, 2020 at 7:40 am
And a new AI tool could track changes in the genetic structure of the SARS-CoV-2 virus. Plus more from this week’s COVID-19 news and research in the clinical research industry. Different groups are ...